117 related articles for article (PubMed ID: 38636499)
1. Comparison of lifetime mortality risk, incidence risk, and DALYs of baseline cancer rates among countries as a benchmark for radiation-related cancer risk.
Hirouchi J; Kujiraoka I; Takahara S; Takada M; Schneider T; Kai M
J Radiol Prot; 2024 Apr; 44(2):. PubMed ID: 38636499
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of cancer-free survival in estimating the lifetime attributable risk of cancer incidence from radiation exposure.
Seo S; Lee DN; Jin YW; Lee WJ; Park S
J Radiol Prot; 2018 Sep; 38(3):N17-N24. PubMed ID: 29749344
[TBL] [Abstract][Full Text] [Related]
3. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
; Fitzmaurice C; Allen C; Barber RM; Barregard L; Bhutta ZA; Brenner H; Dicker DJ; Chimed-Orchir O; Dandona R; Dandona L; Fleming T; Forouzanfar MH; Hancock J; Hay RJ; Hunter-Merrill R; Huynh C; Hosgood HD; Johnson CO; Jonas JB; Khubchandani J; Kumar GA; Kutz M; Lan Q; Larson HJ; Liang X; Lim SS; Lopez AD; MacIntyre MF; Marczak L; Marquez N; Mokdad AH; Pinho C; Pourmalek F; Salomon JA; Sanabria JR; Sandar L; Sartorius B; Schwartz SM; Shackelford KA; Shibuya K; Stanaway J; Steiner C; Sun J; Takahashi K; Vollset SE; Vos T; Wagner JA; Wang H; Westerman R; Zeeb H; Zoeckler L; Abd-Allah F; Ahmed MB; Alabed S; Alam NK; Aldhahri SF; Alem G; Alemayohu MA; Ali R; Al-Raddadi R; Amare A; Amoako Y; Artaman A; Asayesh H; Atnafu N; Awasthi A; Saleem HB; Barac A; Bedi N; Bensenor I; Berhane A; Bernabé E; Betsu B; Binagwaho A; Boneya D; Campos-Nonato I; Castañeda-Orjuela C; Catalá-López F; Chiang P; Chibueze C; Chitheer A; Choi JY; Cowie B; Damtew S; das Neves J; Dey S; Dharmaratne S; Dhillon P; Ding E; Driscoll T; Ekwueme D; Endries AY; Farvid M; Farzadfar F; Fernandes J; Fischer F; G/Hiwot TT; Gebru A; Gopalani S; Hailu A; Horino M; Horita N; Husseini A; Huybrechts I; Inoue M; Islami F; Jakovljevic M; James S; Javanbakht M; Jee SH; Kasaeian A; Kedir MS; Khader YS; Khang YH; Kim D; Leigh J; Linn S; Lunevicius R; El Razek HMA; Malekzadeh R; Malta DC; Marcenes W; Markos D; Melaku YA; Meles KG; Mendoza W; Mengiste DT; Meretoja TJ; Miller TR; Mohammad KA; Mohammadi A; Mohammed S; Moradi-Lakeh M; Nagel G; Nand D; Le Nguyen Q; Nolte S; Ogbo FA; Oladimeji KE; Oren E; Pa M; Park EK; Pereira DM; Plass D; Qorbani M; Radfar A; Rafay A; Rahman M; Rana SM; Søreide K; Satpathy M; Sawhney M; Sepanlou SG; Shaikh MA; She J; Shiue I; Shore HR; Shrime MG; So S; Soneji S; Stathopoulou V; Stroumpoulis K; Sufiyan MB; Sykes BL; Tabarés-Seisdedos R; Tadese F; Tedla BA; Tessema GA; Thakur JS; Tran BX; Ukwaja KN; Uzochukwu BSC; Vlassov VV; Weiderpass E; Wubshet Terefe M; Yebyo HG; Yimam HH; Yonemoto N; Younis MZ; Yu C; Zaidi Z; Zaki MES; Zenebe ZM; Murray CJL; Naghavi M
JAMA Oncol; 2017 Apr; 3(4):524-548. PubMed ID: 27918777
[TBL] [Abstract][Full Text] [Related]
4. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
[TBL] [Abstract][Full Text] [Related]
5. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 DALYs and HALE Collaborators
Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
[TBL] [Abstract][Full Text] [Related]
6. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.
Safiri S; Kolahi AA; Naghavi M;
BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34844997
[TBL] [Abstract][Full Text] [Related]
7. Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.
Little MP; Pawel D; Misumi M; Hamada N; Cullings HM; Wakeford R; Ozasa K
Radiat Res; 2020 Sep; 194(3):259-276. PubMed ID: 32942303
[TBL] [Abstract][Full Text] [Related]
8. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Oesophageal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
[TBL] [Abstract][Full Text] [Related]
9. Regional and national burden of prostate cancer: incidence, mortality, years of life lost, and disability-adjusted life years, in Mexico and Latin America from 1990 to 2019.
Guzman-Esquivel J; Murillo-Zamora E; Ortiz-Mesina M; Galvan-Salazar HR; De-Leon-Zaragoza L; Casarez-Price JC; Delgado-Enciso J; Delgado-Enciso I
Int Urol Nephrol; 2023 Sep; 55(9):2155-2160. PubMed ID: 37273013
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis.
Mubarik S; Yu Y; Wang F; Malik SS; Liu X; Fawad M; Shi F; Yu C
J Adv Res; 2022 Mar; 37():185-196. PubMed ID: 35499053
[TBL] [Abstract][Full Text] [Related]
11. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 DALYs and HALE Collaborators
Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in cumulative mortality risks of cancer, by occupation, in the working population of Japan from 1995 to 2020: a benchmark for radiation risk comparison.
Takada M; Hirouchi J; Kujiraoka I; Takahara S; Schneider T; Kai M
J Radiol Prot; 2024 Mar; 44(1):. PubMed ID: 38422516
[TBL] [Abstract][Full Text] [Related]
13. Mortality and disability-adjusted life years for smoking-attributed cancers from 1990 to 2019 in the north Africa and middle east countries: a systematic analysis for the global burden of disease study 2019.
Rezakhani L; Darbandi M; Khorrami Z; Rahmati S; Shadmani FK
BMC Cancer; 2023 Jan; 23(1):80. PubMed ID: 36694168
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.
Deng Y; Zhao P; Zhou L; Xiang D; Hu J; Liu Y; Ruan J; Ye X; Zheng Y; Yao J; Zhai Z; Wang S; Yang S; Wu Y; Li N; Xu P; Zhang D; Kang H; Lyu J; Dai Z
J Hematol Oncol; 2020 Jul; 13(1):98. PubMed ID: 32690044
[TBL] [Abstract][Full Text] [Related]
15. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013.
Krishnamurthi RV; deVeber G; Feigin VL; Barker-Collo S; Fullerton H; Mackay MT; O'Callahan F; Lindsay MP; Kolk A; Lo W; Shah P; Linds A; Jones K; Parmar P; Taylor S; Norrving B; Mensah GA; Moran AE; Naghavi M; Forouzanfar MH; Nguyen G; Johnson CO; Vos T; Murray CJ; Roth GA;
Neuroepidemiology; 2015; 45(3):177-89. PubMed ID: 26505982
[TBL] [Abstract][Full Text] [Related]
16. Solid cancer risks from radiation exposure for the Australian population.
Wise KN
Australas Phys Eng Sci Med; 2003 Jun; 26(2):53-62. PubMed ID: 12956186
[TBL] [Abstract][Full Text] [Related]
17. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Risk Factor Collaborators
Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
[TBL] [Abstract][Full Text] [Related]
18. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.
India State-Level Disease Burden Initiative Cancer Collaborators
Lancet Oncol; 2018 Oct; 19(10):1289-1306. PubMed ID: 30219626
[TBL] [Abstract][Full Text] [Related]
19. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Respiratory Tract Cancers Collaborators
Lancet Respir Med; 2021 Sep; 9(9):1030-1049. PubMed ID: 34411511
[TBL] [Abstract][Full Text] [Related]
20. Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast.
O'Connor MK; Li H; Rhodes DJ; Hruska CB; Clancy CB; Vetter RJ
Med Phys; 2010 Dec; 37(12):6187-98. PubMed ID: 21302775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
